Cargando…

Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: Implications for targeted EZH2 inhibitor therapy?

Enhancer of Zeste Homolog 2 (EZH2) plays an essential epigenetic role in Diffuse Large B Cell Lymphoma (DLBCL) development. Recurrent somatic heterozygous gain-of-function mutations of EZH2 have been identified in DLBCL, most notably affecting tyrosine 641 (Y641), inducing hyper-trimethylation of H3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dubois, Sydney, Mareschal, Sylvain, Picquenot, Jean-Michel, Viailly, Pierre-Julien, Bohers, Elodie, Cornic, Marie, Bertrand, Philippe, Veresezan, Elena Liana, Ruminy, Philippe, Maingonnat, Catherine, Marchand, Vinciane, Lanic, Hélène, Penther, Dominique, Bastard, Christian, Tilly, Hervé, Jardin, Fabrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599301/ https://www.ncbi.nlm.nih.gov/pubmed/25762637

Ejemplares similares

Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma
por: Dubois, Sydney, et al.
Publicado: (2021)

Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma
por: Fontanilles, Maxime, et al.
Publicado: (2017)

Improving high-resolution copy number variation analysis from next generation sequencing using unique molecular identifiers
por: Viailly, Pierre-Julien, et al.
Publicado: (2021)

Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma
por: Bobée, Victor, et al.
Publicado: (2020)

CD70: A Potential Target in Breast Cancer?
por: Petrau, Camille, et al.
Publicado: (2014)

A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis
por: Penther, Dominique, et al.
Publicado: (2019)

Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort
por: Bohers, Elodie, et al.
Publicado: (2018)

Complete hematologic response after belinostat treatment and allogeneic stem cell transplantation for multiple relapsed/refractory angioimmunoblastic T‐cell lymphoma: A case report
por: Camus, Vincent, et al.
Publicado: (2023)

Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study
por: Camus, Vincent, et al.
Publicado: (2020)

Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles
por: Dubois, Sydney, et al.
Publicado: (2019)

Correlations between baseline (18)F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma
por: Decazes, Pierre, et al.
Publicado: (2020)

Light chain lambda myeloma with fatal AL cardiac amyloidosis in a 21‐year‐old patient: A case report and review
por: Camus, Vincent, et al.
Publicado: (2019)

cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
por: Bohers, Elodie, et al.
Publicado: (2021)

Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay
por: Drieux, Fanny, et al.
Publicado: (2020)

Spontaneous remission in three cases of AML M5 with NPM1 mutation
por: Camus, Vincent, et al.
Publicado: (2015)

UMI-Gen: A UMI-based read simulator for variant calling evaluation in paired-end sequencing NGS libraries
por: Sater, Vincent, et al.
Publicado: (2020)

Successful treatment of T/myeloid mixed‐phenotype acute leukemia with the translocation (10;11)(p13;q14) PICALM/AF10 with 3 + 7 myeloid standard treatment: A case report
por: Krzisch, Daphné, et al.
Publicado: (2021)

XPO1(E571K) Mutation Modifies Exportin 1 Localisation and Interactome in B-Cell Lymphoma
por: Miloudi, Hadjer, et al.
Publicado: (2020)

New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes
por: Maitre, Elsa, et al.
Publicado: (2018)

Prolonged third complete remission after busulfan, thiotepa, and autologous stem cell transplant in a primary central nervous system lymphoma patient
por: Camus, Vincent, et al.
Publicado: (2018)

Transformation of an Unclassified Myeloproliferative Neoplasm with a Rare BCR-JAK2 Fusion Transcript Resulting from the Translocation (9;22)(p24;q11)
por: Chamseddine, A. N., et al.
Publicado: (2015)

EZH2 alterations in follicular lymphoma: biological and clinical correlations
por: Huet, S, et al.
Publicado: (2017)

Multiple cutaneous ulcers revealing a primary cutaneous Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma
por: Tedbirt, Billal, et al.
Publicado: (2020)

Cyberlindnera jadinii (teleomorph Candida utilis) candidaemia in a patient with aplastic anaemia: a case report
por: Treguier, Pauline, et al.
Publicado: (2018)

Retrospective analysis of the safety of peripherally inserted catheters versus implanted port catheters during first‐line treatment for patients with diffuse large B‐cell lymphoma
por: Pénichoux, Juliette, et al.
Publicado: (2022)

A lowered 26S proteasome activity correlates with mantle lymphoma cell lines resistance to genotoxic stress
por: Ben Younes, Khaoula, et al.
Publicado: (2017)

Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling
por: Gros, Audrey, et al.
Publicado: (2022)

Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio
por: Toledano, Mathieu N., et al.
Publicado: (2019)

Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas
por: Candon, Sophie, et al.
Publicado: (2021)

Voltage-Gated Potassium Channel Antibody Paraneoplastic Limbic Encephalitis Associated with Acute Myeloid Leukemia
por: Alcantara, Marion, et al.
Publicado: (2013)

HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological study
por: Dundr, Pavel, et al.
Publicado: (2020)

Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors
por: Hajósi-Kalcakosz, Szofia, et al.
Publicado: (2012)

Evaluation of Immunohistochemical Expression of Enhancer of Zeste Homolog 2 (EZH2) and Its Association With Clinicopathological Variables in Carcinoma Cervix
por: Priya, Aditi, et al.
Publicado: (2023)

P1217: TARGETING HSP110 IN COMBINATION WITH SELINEXOR IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA AND IN CLASSICAL HODGKIN LYMPHOMA INHIBITS STAT6 ACTIVATION AND IMPAIRS LYMPHOMA CELL GROWTH
por: Durand, Manon, et al.
Publicado: (2023)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

Diagnostic Utility of BAP1, EZH2 and Survivin in Differentiating Pleural Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia: Immunohistochemical Study
por: Hakim, Sarah Adel, et al.
Publicado: (2021)

Differential Diagnosis of Cystic Pancreatic Lesions Including the Usefulness of Biomarkers
por: Lévy, Philippe, et al.
Publicado: (2015)

Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study
por: Pénichoux, Juliette, et al.
Publicado: (2023)

Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor
por: Clatot, Florian, et al.
Publicado: (2016)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
por: Shinohara, Haruka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e76ae941hqdogjoi3tt319i37j